Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 4Phase 1/2 2Phase NA 1Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 1044Neoplasms 876Prostatic Neoplasms 507Lung Neoplasms 422Colorectal Neoplasms 358Motor Activity 220Head and Neck Neoplasms 194Uterine Cervical Neoplasms 190Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 173Pancreatic Neoplasms 160Ovarian Neoplasms 138Colonic Neoplasms 137Carcinoma, Hepatocellular 136Anxiety Disorders 124Rectal Neoplasms 117Hematologic Neoplasms 115Multiple Myeloma 106Stomach Neoplasms 103Neoplasm Metastasis 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 94Depression 93Melanoma 92Urinary Bladder Neoplasms 88Pain 87Endometrial Neoplasms 86Glioblastoma 84Disease 83Lymphoma 81Sarcoma 78

Interventions

regorafenib 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hemangiosarcoma × 1 year × Clear all
NCT04055220 2026-02-17

REGOSTA

Centre Leon Berard

Phase NA Recruiting
168 enrolled
Sarcoma

Pathologic Complete Response, Bone Neoplasms, Chondrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Patient Compliance, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡